Immune function status of postoperative patients with colon cancer for predicting liver metastasis

Table 1 Comparison of baseline data and laboratory indicators of patients between the two groups

Data		Occurrence group (n = 100)	Non-occurrence group (n = 100)	Statistical values	P value
Sex	Male	61 (61.00)	58 (58.00)	χ2 = 0.187	0.666
	Female	39 (39.00)	42 (42.00)
Age		63.02 ± 3.88 (49-71)	62.25 ± 3.75 (53-71)	t = 1.427	0.155
Tumor site	Right hemicolon	40 (40.00)	45 (45.00)	χ2 = 0.512	0.475
	Left hemicolon	60 (60.00)	55 (55.00)
Tumor typing	Infiltration type	22 (22.00)	30 (30.00)	χ2 = 0.189	0.389
	Ulcer type	35 (35.00)	30 (30.00)
	Uplift type	45 (45.00)	40 (40.00)
CEA (μg/L)		8.95 ± 1.30	5.25 ± 1.52	t = 18.499	< 0.001
CA19-9 (IU/mL)		42.25 ± 8.25	22.56 ± 4.58	t = 20.867	< 0.001
CA242 (U/mL)		142.25 ± 20.52	85.65 ± 15.05	t = 17.055	< 0.001
CA72-4 (U/mL)		55.85 ± 10.58	23.25 ± 5.28	t = 27.570	< 0.001
CA50 (U/mL)		42.25 ± 6.25	32.15 ± 4.20	t = 13.413	< 0.001
CD3+ (%)		53.45 ± 5.52	67.50 ± 8.40	t = 13.978	< 0.001
CD4+ (%)		26.58 ± 3.45	37.35 ± 4.10	t = 20.100	< 0.001
CD8+ (%)		24.52 ± 4.10	33.02 ± 6.50	t = 11.060	< 0.001
NK (%)		31.25 ± 3.85	45.20 ± 5.15	t = 21.695	< 0.001
CD4+/CD25 (%)		5.10 ± 2.15	9.52 ± 3.56	t = 10.628	< 0.001

CEA: Carcinoembryonic antigen; NK: Natural killer.